1-4 of 4
Keywords: Coronavirus Disease 2019
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

Correction: Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6

Journal: Bioscience Reports
Biosci Rep (2021) 41 (2): BSR-20202583_COR.
https://doi.org/10.1042/BSR-20202583_COR
Published: 23 February 2021
... Attribution License 4.0 (CC BY) . Coronavirus Disease 2019 Interleukin-6 traditional Chinese medicine The authors of the original article “Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6” (Biosci Rep (2021...
View article titled, Correction: Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6
Open the PDF for Correction: Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6 in another window
Articles

Hyperglycemia at admission is a strong predictor of mortality and severe/critical complications in COVID-19 patients: a meta-analysis

In Collection
Coronavirus
Yan Yang, Zixin Cai, Jingjing Zhang
Journal: Bioscience Reports
Biosci Rep (2021) 41 (2): BSR20203584.
https://doi.org/10.1042/BSR20203584
Published: 10 February 2021
...Yan Yang; Zixin Cai; Jingjing Zhang Background: Hyperglycemia at admission has been demonstrated to exacerbate the outcomes of coronavirus disease 2019 (COVID-19) but a meta-analysis is lacking to further confirm this hypothesis. The purpose of this meta-analysis was to summarize the evidence...
View article titled, Hyperglycemia at admission is a strong predictor of mortality and severe/critical complications in COVID-19 patients: a meta-analysis
Open the PDF for Hyperglycemia at admission is a strong predictor of mortality and severe/critical complications in COVID-19 patients: a meta-analysis in another window
Includes: Supplementary data
Articles

Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6

In Collection
Coronavirus
Wen-hao Niu, Feng Wu, Wen-yue Cao, Zong-gui Wu, Yu-Chieh Chao, Fei Peng, Chun Liang
Journal: Bioscience Reports
Biosci Rep (2021) 41 (1): BSR20202583.
https://doi.org/10.1042/BSR20202583
Published: 14 January 2021
... to be effective for coronavirus disease 2019 (COVID-19) treatment. The present study aimed to identify the active chemical constituents of this traditional Chinese medicine (TCM) and investigate their mechanisms through interleukin-6 (IL-6) integrating network pharmacological approaches. Methods: We collected...
View article titled, Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6
Open the PDF for Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6 in another window
Includes: Supplementary data
Articles

Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy

In Collection
Coronavirus
Anas Shamsi, Taj Mohammad, Saleha Anwar, Mohamed F. AlAjmi, Afzal Hussain, Md. Tabish Rehman, Asimul Islam, Md. Imtaiyaz Hassan
Journal: Bioscience Reports
Biosci Rep (2020) 40 (6): BSR20201256.
https://doi.org/10.1042/BSR20201256
Published: 02 June 2020
... 2020 22 05 2020 22 05 2020 © 2020 The Author(s). 2020 This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) . Coronavirus disease 2019 drug repurposing...
View article titled, Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy
Open the PDF for Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy in another window